Role of neoadjuvant chemotherapy in congenital intracranial haemangiopericytoma

Pediatr Blood Cancer. 2011 Jan;56(1):161-3. doi: 10.1002/pbc.22726.

Abstract

Infantile haemangiopericytoma of the CNS is a rare entity. We report the first case of a congenital haemangiopericytoma successfully treated by preoperative chemotherapy. The patient presented shortly after birth with the diagnosis of a haemangiopericytoma. As neurosurgery was too risky due to size, location and age of the patient an anthracycline-based chemotherapeutic regimen was applied and resulted in a significant decrease in tumour size, making a postchemotherapy complete surgical resection possible. Chemotherapy may benefit patients with congenital haemangiopericytoma especially if the tumour cannot initially be treated by complete neurosurgical resection.

Publication types

  • Case Reports

MeSH terms

  • Anthracyclines / therapeutic use
  • Brain Neoplasms / congenital
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Female
  • Hemangiopericytoma / congenital
  • Hemangiopericytoma / drug therapy*
  • Hemangiopericytoma / surgery
  • Humans
  • Infant, Newborn
  • Neoadjuvant Therapy / methods*
  • Preoperative Care

Substances

  • Anthracyclines